https://www.urologytimes.com/view/study-evaluates-costs-of-overactive-bladder-medications
0
0
36 words
0
Comments
“Our aim overall is to describe Medicare Part D prescription drug coverage and use of prior authorization and step therapy for these medications,” says Katherine Shapiro, MD.
You are the first to view
Create an account or login to join the discussion